Saurashtra News

With 21.6% CAGR, Global Single-use Bioreactors Market Size Estimated to Cross USD 17.97 Billion by 2030: Polaris Market Research

 Breaking News
  • No posts were found

With 21.6% CAGR, Global Single-use Bioreactors Market Size Estimated to Cross USD 17.97 Billion by 2030: Polaris Market Research

May 03
21:09 2022
With 21.6% CAGR, Global Single-use Bioreactors Market Size Estimated to Cross USD 17.97 Billion by 2030: Polaris Market Research
According to the research report, the global single-use bioreactors market size was valued at USD 3.43 Billion in 2021 and is expected to reach USD 17.97 Billion by 2030, to grow at a CAGR of 21.6% during the forecast period.

According to the research report, the global single-use bioreactors market size was valued at USD 3.43 Billion in 2021 and is expected to reach USD 17.97 Billion by 2030, to grow at a CAGR of 21.6% during the forecast period.

What are Single-use bioreactors? How big is Single-use Bioreactors Market?

  • Overview


Single-use bioreactors are becoming an alternative significant technology in mammalian cell culture and pharmaceutical applications being particularly favorable for biopharmaceutical products were operating in trends ask for speedy, flexible, and uncomplicated distribution. Implementing single used bioreactors lessens the probability of cross-contamination and intensifies procedure safety in extremely potent biopharmaceutical components with substantial validation and qualification processes. Benefits include lesser maintenance and preparation time.

Single-use bioreactors are bioreactors that utilize a disposable bag rather than a culture vessel consisting of stainless steel or glass. The most common are cultivation and storage bags. Pharmaceutical companies use single-use bioreactors for buffer and media preparation, cell harvesting, filtration, purification, and virus immobilization. The bags are created of multilayer polymer film and arrive gamma sterilized from the suppliers. The lining of the bioreactor bag that touches the cell culture is commonly polyethylene. The bag is then enclosed in a sturdier structure, usually a steel, cuboid, or rocker cylinder.

Request Sample Copy of Research Report @

(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)

Highlights of the report

  • The study offers a detailed analysis of the bioreactors market, and prevailing trends and succeeding estimations to explain impending pockets of investment
  • It showcases a quantitative analysis of the market over the forecast period to authorize stakeholders to maximize the existing bioreactor’s opportunities in the market
  • In-depth analysis of the bioreactors market depending on procedures and services helps to comprehend the trends in the industry
  • Prominent players and their programs are exhaustively analyzed to comprehend the competitive outlook of the bioreactors market
  • Substantial analysis of the industry is executed by monitoring the top contenders by supporting the essential product situated within the framework of the market


Top Market Players Are:

  • ABLE Corporation & Biott Corporation
  • BBI-Biotech GMBH
  • Cellexus
  • Celltainer Biotech BV
  • Cesco Bioengineering Co. Ltd.
  • Danaher Corporation
  • Distek Inc.
  • Eppendorf AG
  • G&G Technologies Inc.
  • Getinge AB
  • Meissner Filtration Products Inc.
  • Merck Millipore
  • PBS Biotech Inc.
  • Sartorius AG
  • Solida Biotech GMBH
  • Stobbe Pharma GMBH
  • Thermo Fisher Scientific Inc


Request for Discount on this Report Before Purchase @

Single-use bioreactors market: Growth leading factors

Growth of the global bioreactor market is prominently driven by the increase in demand for monoclonal antibiotics, growth in funding from private and government firms for advancement in the vaccine, rise in demand for single-use bioreactors, and growth in improvement in the pharmaceutical and biotechnology industry. For instance, in 2019, Applikon Biotechnology, a mass-producing company exclusive in challenging bioprocess equipment, launched a single-use AppliFlex ST lab-scale bioreactor, a made-to-order single-use bioreactor is offered with pre disinfecting all set system to save time and while cell culture set up.

Further, growth in technological advancements for advanced bioreactors and development in the design of the equipment for bioprocessing fuels for bioreactors market growth in the forecast period. Additionally, in 2021, Beckman Coulter Life Science, a Danaher Corporation occupied in healthcare advancement, initiated a new BioLector XT Microbioreactor, which sanctions escalated output strain screening, feeding strategy optimization, and observing of parameters of cultivation. It also can garner data that is high quality in a short period by utilizing minimum manual mechanisms.

The covid-19 pandemic is expected to influence the development of the global bioreactors market development positively. The covid-19 pandemic has emphasized the healthcare system in the world and raised the requirement for vaccine and monoclonal antibodies for the prohibition and cure of patients enduring coronavirus.

Directly Purchase a copy of the report with TOC @

Single-use bioreactors market: Report Scope

Report Attribute


Market Size 2021 Value

USD 3.43 billion

Market Outlook for 2030

USD 17.97 billion

Expected CAGR Growth

21.6% from 2022 – 2030

Base year


Forecast period

2022 – 2030

Segments covered

By Product, By Cell, By Molecule, By End-Use, By Region

Key Companies

ABLE Corporation & Biott Corporation, BBI-Biotech GMBH, Cellexus, Celltainer Biotech BV, Cesco Bioengineering Co., Ltd., Danaher Corporation, Distek, Inc., Eppendorf AG, G&G Technologies, Inc., Getinge AB, Meissner Filtration Products, Inc., Merck Millipore, PBS Biotech, Inc., Sartorius AG, Solida Biotech GMBH, Stobbe Pharma GMBH, and Thermo Fisher Scientific Inc.

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Customization Options

Customized purchase options are available to meet your research needs.


Single-use bioreactors market: Key segmentation

  • Insight by product, cell, molecule, end-use, and region


By product, single-use bioreactor systems hold the most significant revenue share due to widespread acceptance of SUB systems, and technological advancements have pushed the segment growth. By cell, the mammalian cell segment seized the largest revenue share owing to mammalian cell cultures playing a vital role in biopharmaceutical product manufacturing. By molecules, the vaccine segment ruled the market with a high revenue share due to the global outbreak of the SARS-CoV-2 virus bringing about an essential requirement for an effective vaccine against the virus. By end-use, the CMO and CRO segments were considered the most significant revenue share because the demand for more flexible production dimensions and speedy campaign transformations is high amongst CMOS.

By region, North America seized the most significant revenue share because of prominent operating players and the entrenched biopharmaceutical industry in the area. Further, the augmentation of manufacturing capacities in this region has amplified the market growth. Asia Pacific is approaching to record the speediest CAGR throughout the forecast period. It is gauged that about 50% of the novel bioprocessing facilities globally are being accepted by Asian companies, including international giants and domestic players. This is anticipated to predominantly drive the Asia Pacific market in the time to come. China is expected to be on the platform because of the high adoption of single-use technology.

Browse the full “Single-use Bioreactors Market Share, Size, Trends, Industry Analysis Report, By Product (Bioreactor Systems, Media Bags, Filtration Assemblies, Others); By Cell (Mammalian, Bacteria, Yeast, Others); By Molecule; End-Use; By Region; Segment Forecast, 2022 – 2030” Report at

Important Questions Being Answered by The Market Report

  • What is the market size and growth?
  • What is the aggregate market value of the bioreactors market report?
  • What would be the forecast period in a market report?
  • Which is the base year calculated in the bioreactors market report?
  • Does the bioreactors company profile in the report?
  • Which are the top companies holding the market share in the bioreactors market?


The market primarily depends on the product, cell, molecule, end-use, and region

Single-use bioreactors market: By product

  • Bioreactor Systems
  • Media Bags
  • Filtration Assemblies
  • Others


Single-use bioreactors market: By cell

  • Mammalian Cell 
  • Bacteria
  • Yeast
  • Others


Single-use bioreactors market: By molecule

  • Vaccines 
  • Monoclonal Antibodies
  • Stem Cells
  • Recombinant Proteins
  • Others


Single-use bioreactors market: By end-use

  • Pharmaceutical & Biopharmaceutical Industries
  • Contract Research Organizations (CRO)
  • Others


About Us:

Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defense, among different ventures, present globally.

Media Contact
Company Name: Polaris Market Research and Consulting
Contact Person: Likhil
Email: Send Email
Phone: +1-9292-97-97-27
Address:30 Wall Street 8th Floor, New York City, NY 10005, United States
City: New York City
State: US
Country: United States